Biological
Aspartyl-alanyl-diketopiperazine clinical trials
Also written Ampion.
- studies test it
- 14
- open now
- 0
- in phase 3
- 6
- first study started
- 2013
How studies write it
Studies that test it under each name
Brand
Studies by the year they started
14 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 4
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
Ampio Pharmaceuticals. Inc. (14)
Studies
Open first, then newest update. How each study uses aspartyl-alanyl-diketopiperazine is read from its arms, and is right about nine times in ten.
Testing it · 14
- A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)CompletedPhase 1Ampio Pharmaceuticals. Inc.NCT04880161Written as Ampion
- A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19TerminatedPhase 2Ampio Pharmaceuticals. Inc.NCT04868890Written as Ampion
- Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental OxygenTerminatedPhase 2Ampio Pharmaceuticals. Inc.NCT04839965Written as Ampion
- Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.TerminatedPhase 3Ampio Pharmaceuticals. Inc.NCT03988023Written as Ampion
- Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the KneeTerminatedPhase 3Ampio Pharmaceuticals. Inc.NCT03349645Written as 4 mL injection of AMPION™
- A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis PainCompletedPhase 1/2Ampio Pharmaceuticals. Inc.NCT02184156Written as 4 mL injection of Ampion
- A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in OsteoarthritisCompletedPhase 3Ampio Pharmaceuticals. Inc.NCT02242435Written as 4 mL injection of Ampion
- A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in KneeCompletedPhase 3Ampio Pharmaceuticals. Inc.NCT02024529Written as 4 mL injection of Ampion
- AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the KneeCompletedPhase 3Ampio Pharmaceuticals. Inc.NCT03182686Written as 4 mL injection of Ampion
- A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the KneeCompletedPhase 3Ampio Pharmaceuticals. Inc.NCT02556710Written as 4 mL injection of AMPION™
- An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the KneeCompletedPhase 2Ampio Pharmaceuticals. Inc.NCT01839331Written as 4 mL injection of Ampion
- Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory DistressCompletedPhase 1Ampio Pharmaceuticals. Inc.NCT04606784Written as Ampion
- Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen SupplementationCompletedPhase 1Ampio Pharmaceuticals. Inc.NCT04456452Written as Ampion
- AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb JointCompletedPhase 1Ampio Pharmaceuticals. Inc.NCT02762760Written as AMPION™
Codes
What other systems call aspartyl-alanyl-diketopiperazine · ClinicalTrials.gg INT005216
- MeSH (NLM) C526103aspartyl-alanyl-diketopiperazineOne source NLM
- UNII (FDA) R9CHM391D5ASPARTYL-ALANYL-DIKETOPIPERAZINEConfirmed NLM, Wikidata
- Wikidata Q27288007aspartyl-alanyl-diketopiperazineConfirmed NLM, Wikidata
- DrugBank DB14940One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C526103 | aspartyl-alanyl-diketopiperazine | One source NLM |
| UNII (FDA) | R9CHM391D5 | ASPARTYL-ALANYL-DIKETOPIPERAZINE | Confirmed NLM, Wikidata |
| Wikidata | Q27288007 | aspartyl-alanyl-diketopiperazine | Confirmed NLM, Wikidata |
| DrugBank | DB14940 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.